Health

Stalled Research Leaves Families Facing Rare Pediatric Cancer

When Ryleigh Schecter answered the front door to her home in Twinsburg, Ohio, she wore an oversized lavender bow that matched the stripes on her shirt. “Rainbow” is her favorite color, she told visitors as she sat with her parents, Amanda and Aaron, in their living room. To demonstrate, she recited the colors of the spectrum in order, adding “pink, silver, gold” at the end. She is 5 years old.

Eventually, the conversation turned to the medicine she takes. On cue, Ryleigh sped to the kitchen and raced back carrying a sandwich bag full of Skittles containing only red, orange, and yellow candies. “I don’t like the purple or the green,” she explained.

image

Ryleigh takes two drugs every night, including one designed to treat breast cancer. Her mother mixes them as if from a chemistry set and administers them orally with a syringe. Ryleigh detests the routine. “The first one tastes disgusting, and the second one tastes medium,” Ryleigh said. When asked what the first one tastes like, she replied, “Dirty water mixed together.” After each dose, Ryleigh eats a Skittle to wash away the taste, noting that she likes orange best.

Evelyn Price

Evelyn Price covers health news, medical research, public health developments, and wellness topics. She aims to present evidence-based information in clear language, helping readers understand important studies, health policies, and advances in medicine.
Back to top button